Replies to post #338817 on NorthWest Biotherapeutics Inc (NWBO)

[moderation23]

To take it a step further, in describing project 1 of their SPORE, UCLA adds the L on their website.

Finally, in Aim 3, we will develop and validate predictive tumor, immunological and imaging biomarkers of response in recurrent glioblastoma patients enrolled in a Phase II clinical trial of DCVax-L +/- PD-1 blockade.

https://cancer.ucla.edu/research/ucla-brain-spore/research-projects

JR has speculated that there is some sort of row going on between LL and NWBO, but I've seen absolutely not a shred of evidence on this board to support it.